142 related articles for article (PubMed ID: 12119329)
1. Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel.
Celletti FL; Waugh JM; Amabile PG; Kao EY; Boroumand S; Dake MD
J Vasc Interv Radiol; 2002 Jul; 13(7):703-7. PubMed ID: 12119329
[TBL] [Abstract][Full Text] [Related]
2. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia.
Hopkins SP; Bulgrin JP; Sims RL; Bowman B; Donovan DL; Schmidt SP
J Vasc Surg; 1998 May; 27(5):886-94; discussion 895. PubMed ID: 9620141
[TBL] [Abstract][Full Text] [Related]
3. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion.
Mack CA; Magovern CJ; Budenbender KT; Patel SR; Schwarz EA; Zanzonico P; Ferris B; Sanborn T; Isom P; Ferris B; Sanborn T; Isom OW; Crystal RG; Rosengart TK
J Vasc Surg; 1998 Apr; 27(4):699-709. PubMed ID: 9576084
[TBL] [Abstract][Full Text] [Related]
4. Malignant ascites fluid (MAF), including ovarian-cancer-associated MAF, contains angiostatin and other factor(s) which inhibit angiogenesis.
Richardson M; Gunawan J; Hatton MW; Seidlitz E; Hirte HW; Singh G
Gynecol Oncol; 2002 Sep; 86(3):279-87. PubMed ID: 12217749
[TBL] [Abstract][Full Text] [Related]
5. Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis.
Cleland JL; Duenas ET; Park A; Daugherty A; Kahn J; Kowalski J; Cuthbertson A
J Control Release; 2001 May; 72(1-3):13-24. PubMed ID: 11389981
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways.
Eriksson K; Magnusson P; Dixelius J; Claesson-Welsh L; Cross MJ
FEBS Lett; 2003 Feb; 536(1-3):19-24. PubMed ID: 12586331
[TBL] [Abstract][Full Text] [Related]
7. Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque.
Celletti FL; Hilfiker PR; Ghafouri P; Dake MD
J Am Coll Cardiol; 2001 Jun; 37(8):2126-30. PubMed ID: 11419898
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.
Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM
Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799
[TBL] [Abstract][Full Text] [Related]
9. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia.
Takeshita S; Pu LQ; Stein LA; Sniderman AD; Bunting S; Ferrara N; Isner JM; Symes JF
Circulation; 1994 Nov; 90(5 Pt 2):II228-34. PubMed ID: 7525111
[TBL] [Abstract][Full Text] [Related]
11. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of neointima formation with tissue-type plasminogen activator.
Hilfiker PR; Waugh JM; Li-Hawkins JJ; Kuo MD; Yuksel E; Geske RS; Cifra PN; Chawla M; Weinfeld AB; Thomas JW; Shenaq SM; Dake MD
J Vasc Surg; 2001 Apr; 33(4):821-8. PubMed ID: 11296338
[TBL] [Abstract][Full Text] [Related]
13. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells.
Redlitz A; Daum G; Sage EH
J Vasc Res; 1999; 36(1):28-34. PubMed ID: 10050071
[TBL] [Abstract][Full Text] [Related]
14. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
Henry TD; Annex BH; McKendall GR; Azrin MA; Lopez JJ; Giordano FJ; Shah PK; Willerson JT; Benza RL; Berman DS; Gibson CM; Bajamonde A; Rundle AC; Fine J; McCluskey ER;
Circulation; 2003 Mar; 107(10):1359-65. PubMed ID: 12642354
[TBL] [Abstract][Full Text] [Related]
15. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery.
Asahara T; Bauters C; Pastore C; Kearney M; Rossow S; Bunting S; Ferrara N; Symes JF; Isner JM
Circulation; 1995 Jun; 91(11):2793-801. PubMed ID: 7758186
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.
Fabre JE; Rivard A; Magner M; Silver M; Isner JM
Circulation; 1999 Jun; 99(23):3043-9. PubMed ID: 10368123
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury.
Widenfalk J; Lipson A; Jubran M; Hofstetter C; Ebendal T; Cao Y; Olson L
Neuroscience; 2003; 120(4):951-60. PubMed ID: 12927201
[TBL] [Abstract][Full Text] [Related]
18. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.
Henry TD; Rocha-Singh K; Isner JM; Kereiakes DJ; Giordano FJ; Simons M; Losordo DW; Hendel RC; Bonow RO; Eppler SM; Zioncheck TF; Holmgren EB; McCluskey ER
Am Heart J; 2001 Nov; 142(5):872-80. PubMed ID: 11685177
[TBL] [Abstract][Full Text] [Related]
19. Stent-based controlled release of intravascular angiostatin to limit plaque progression and in-stent restenosis.
Ganaha F; Kao EY; Wong H; Elkins CJ; Lee J; Modanlou S; Rhee C; Kuo MD; Yuksel E; Cifra PN; Waugh JM; Dake MD
J Vasc Interv Radiol; 2004 Jun; 15(6):601-8. PubMed ID: 15178721
[TBL] [Abstract][Full Text] [Related]
20. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta.
Hiltunen MO; Laitinen M; Turunen MP; Jeltsch M; Hartikainen J; Rissanen TT; Laukkanen J; Niemi M; Kossila M; Häkkinen TP; Kivelä A; Enholm B; Mansukoski H; Turunen AM; Alitalo K; Ylä-Herttuala S
Circulation; 2000 Oct; 102(18):2262-8. PubMed ID: 11056103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
